期刊
WORLD JOURNAL OF HEPATOLOGY
卷 10, 期 10, 页码 670-684出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4254/wjh.v10.i10.670
关键词
Direct acting anti-viral agents; Hepatitis C virus infection; Post-liver transplant; Hepatitis C virus/human immunodeficiency virus co-infection
Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone. Now we have stepped into the era of direct acting anti-viral agents (DAAs) against hepatitis C virus. Treatment of hepatitis C is now extremely effective, tolerable and requires a short duration of intake of oral agents. Less monitoring is required with the current therapy and drug-drug interactions are less than the previous regimen. The current treatment options of chronic hepatitis C with various DAAs are discussed in this article. (c) The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据